TO THE EDITOR:

Fibrin-associated large B-cell lymphoma (FA-LBCL) is a microscopic proliferation of large B cells arising in association with fibrinous debris in specific anatomic locations, including cardiac valves and myxomas, preexisting cysts or pseudocysts, and chronic hematomas or thrombi.1,2 Some of these locations are associated with the presence of foreign bodies, especially artificial cardiac valves and endovascular grafts, whereas others arise in the context of native tissue.

The pathophysiology of FA-LBCL is largely unknown; however, a few potential pathogenic mechanisms have been proposed. The lymphoma cells in most cases are positive for Epstein-Barr virus (EBV) and express EBV latent membrane proteins and EBV nuclear antigens (type III latency), which is unusual for lymphoma in immunocompetent patients because of the immunogenicity of these viral proteins. This has led to the hypothesis that the lymphoma cells are obliged to...

1.
Loong
F
,
Chan
AC
,
Ho
BC
, et al
.
Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios
.
Mod Pathol
.
2010
. ;
23
(
4
):
493
-
501
.
2.
Boyer
DF
,
McKelvie
PA
,
de Leval
L
, et al
.
Fibrin-associated EBV-positive large B-cell lymphoma: an indolent neoplasm with features distinct from diffuse large B-cell lymphoma associated with chronic inflammation
.
Am J Surg Pathol
.
2017
. ;
41
(
3
):
299
-
312
.
3.
Aguilar
C
,
Beltran
B
,
Quiñones
P
, et al
.
Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus?
.
Cardiovasc Pathol
.
2015
. ;
24
(
1
):
60
-
64
.
4.
Yan
J
,
Luo
D
,
Zhang
F
, et al
.
Diffuse large B cell lymphoma associated with chronic inflammation arising within atrial myxoma: aggressive histological features but indolent clinical behaviour
.
Histopathology
.
2017
. ;
71
(
6
):
951
-
959
.
5.
Habib
PM
,
Serena
T
,
Flynn
CM
, et al
.
Incidental pathogenic fibrin-associated diffuse large B-cell lymphoma found during aorto-biiliac bypass
.
Cureus
.
2022
. ;
14
(
3
):
e23681
.
6.
Song
JY
,
Perry
AM
,
Herrera
AF
, et al
.
Double-hit signature with TP53 abnormalities predicts poor survival in patients with germinal center type diffuse large B-cell lymphoma treated with R-CHOP
.
Clin Cancer Res
.
2021
. ;
27
(
6
):
1671
-
1680
.
7.
Wright
GW
,
Huang
DW
,
Phelan
JD
, et al
.
A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications
.
Cancer Cell
.
2020
. ;
37
(
4
):
551
-
568.e14
.
8.
Baugh
L
,
Brown
N
,
Song
JY
,
Pandya
S
,
Montoya
V
,
Perry
AM
.
Fibrin-associated, EBV-negative diffuse large B-cell lymphoma arising in atrial myxoma: expanding the spectrum of the entity
.
Int J Surg Pathol
.
2022
. ;
30
(
1
):
39
-
45
.
9.
Kataoka
K
,
Miyoshi
H
,
Sakata
S
, et al
.
Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas
.
Leukemia
.
2019
. ;
33
(
7
):
1687
-
1699
.
10.
Polprasert
C
,
Takeuchi
Y
,
Makishima
H
, et al
.
Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas
.
Leuk Lymphoma
.
2021
. ;
62
(
1
):
95
-
103
.
11.
Lenz
G
,
Davis
RE
,
Ngo
VN
, et al
.
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
.
Science
.
2008
. ;
319
(
5870
):
1676
-
1679
.
12.
Davis
RE
,
Ngo
VN
,
Lenz
G
, et al
.
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
.
Nature
.
2010
. ;
463
(
7277
):
88
-
92
.
13.
Montes-Moreno
S
,
Odqvist
L
,
Diaz-Perez
JA
, et al
.
EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
.
Mod Pathol
.
2012
. ;
25
(
7
):
968
-
982
.
14.
Pfeifer
M
,
Grau
M
,
Lenze
D
, et al
.
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
.
Proc Natl Acad Sci U S A
.
2013
. ;
110
(
30
):
12420
-
12425
.
15.
Wang
X
,
Cao
X
,
Sun
R
, et al
.
Clinical significance of PTEN deletion, mutation, and loss of PTEN expression in de novo diffuse large B-cell lymphoma
.
Neoplasia
.
2018
. ;
20
(
6
):
574
-
593
.
16.
Hongyo
T
,
Kurooka
M
,
Taniguchi
E
, et al
.
Frequent p53 mutations at dipyrimidine sites in patients with pyothorax-associated lymphoma
.
Cancer Res
.
1998
. ;
58
(
6
):
1105
-
1107
.
17.
Cabagnols
X
,
Favale
F
,
Pasquier
F
, et al
.
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients
.
Blood
.
2016
. ;
127
(
3
):
333
-
342
.
18.
Oishi
N
,
Brody
GS
,
Ketterling
RP
, et al
.
Genetic subtyping of breast implant-associated anaplastic large cell lymphoma
.
Blood
.
2018
. ;
132
(
5
):
544
-
547
.
19.
Mescam
L
,
Camus
V
,
Schiano
JM
, et al
.
EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas
.
Blood
.
2020
. ;
135
(
22
):
2004
-
2009
.
20.
Oishi
N
,
Feldman
AL
.
CA9 expression in breast implant-associated anaplastic large cell lymphoma presenting in a lymph node
.
Histopathology
.
2022
. ;
81
(
2
):
270
-
272
.
21.
Erdmann
T
,
Klener
P
,
Lynch
JT
, et al
.
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL
.
Blood
.
2017
. ;
130
(
3
):
310
-
322
.
You do not currently have access to this content.
Sign in via your Institution